The costs of gutting the drug control policy office

President Trump holding up a signed memo
President Trump holding up a signed memorandum on combatting the opioid crisis last year. Photo: Brendan Smialowski / AFP / Getty Images

The West Wing has thoroughly marginalized the Office of National Drug Control Policy, Politico reported yesterday, pushing aside seasoned policy staff while presidential adviser Kellyanne Conway relies on political aides to craft the White House’s response to the opioid crisis.

Why it matters: ONDCP is a part of the administration, similar to the White House budget office, and would normally be running point on issues like opioids. The opioid crisis is ravaging American communities at a shocking rate. It has gone on so long, and gotten so severe, that it clearly needs a public-policy response.